New Strategies for Individualizing Treatment in DME
Luis A. Gonzalez, MD, MPH
Jeremiah Brown Jr., MD, MS, FASRS
SunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Vera Bril, MD
Neelam Goyal, MD
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
Nicholas J. Silvestri, MD
Hans Katzberg, MD
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Managing Side Effects in FcRn Therapy: Best Practices for gMG
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
Personalizing Care Within the RCC Treatment Paradigm
Eric Jonasch, MD
Brad McGregor, MD
Ulka Vaishampayan, MBBS
What’s New in Glaucoma Topical Therapies?
Justin Schweitzer, OD, FAAO
Sarah H. Van Tassel, MD
What’s New With 3D Visualization in Glaucoma Surgery?
Paul Petrakos, DO, MS
I. Paul Singh, MD
What’s New in Schlemm’s Canal MIGS?
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
World Obesity Day: Call to Action
Donna Ryan, MD
Ricardo Cohen, MD, PhD
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.